Pharmacological targets to inhibit alzheimer neurofibrillary degeneration

  • K. Iqbal
  • A.C. del Alonso
  • E. El-Akkad
  • C.-X. Gong
  • N. Haque
  • S. Khatoon
  • I. Tsujio
  • I. Grundke-Iqbal
Part of the Journal of Neural Transmission. Supplementa book series (NEURAL SUPPL, volume 62)


Neurofibrillary degeneration appears to be required for the clinical expression of Alzheimer disease (AD) and related tauopathies. Given the polyetiology of these diseases and the pivotal involvement of neurofibrillary degeneration in their pathogenesis, inhibition of this lesion offers a promising therapeutic target. Studies from our laboratories have shown that there is a protein phosphorylation/dephosphorylation imbalance and that the microtubule associated protein tau is abnormally hyperphosphorylated in the brain of patients with AD and in this form it is the major protein subunit of paired helical filaments/neurofibrillary tangles (PHF/NFT). The abnormal tau which is polymerized into PHF/NFT neither promotes or inhibits in vitro microtubule assembly. In contrast the cytosolic abnormally hyperphosphorylated tau from AD brain, the AD P-tau neither associates with tubulin nor promotes in vitro microtubule assembly but instead it sequesters normal tau, MAPI and MAP2 and inhibits microtubule assembly. The AD P-tau readily self-assembles in vitro into tangles of PHF/straight filaments under physiological conditions of protein concentration, pH, ionic strength and reducing conditions and this self assembly requires the abnormal hyperphosphorylation of this protein. The activity of phosphoseryl/phosphothreonyl protein phosphatase (PP)-2A which regulates the phosphorylation of tau, is compromised in AD brain. Thus, modulation of the activities of protein phosphatase-2A and tau kinases and inhibition of the sequestration of normal MAPs by AD P-tau offer promising therapeutic opportunities to inhibit neurofibrillary degeneration and the diseases characterized by this lesion.


Alzheimer Disease Microtubule Assembly Paired Helical Filament Alzheimer Disease Brain Neurofibrillary Degeneration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alafuzoff I, Iqbal K, Friden H, Adolfson R, Winblad B (1987) Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berlin) 74: 209–225CrossRefGoogle Scholar
  2. Alonso A del C, Zaidi T, Grundke-Iqbal I, Iqbal K (1994) Role of abnormally phosphory-lated tau in the breakdown of microtubules in Alzheimer disease. Proc Natl Acad Sci USA 91: 5562–5566CrossRefGoogle Scholar
  3. Alonso A del C, Grundke-Iqbal I, Iqbal K (1996) Alzheimer’s disease hyperphos-phorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat Med 2: 783–787CrossRefGoogle Scholar
  4. Alonso A del C, Grundke-Iqbal I, Barra HS, Iqbal K (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of MAPI and MAP2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci USA 94: 298–303CrossRefGoogle Scholar
  5. Alonso A del C, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001a) Hyperpho-sphorylation induces self ¡ª assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98: 6923–6928CrossRefGoogle Scholar
  6. Alonso A del C, Zaidi T, Novak HS, Barra HS, Grundke-Iqbal I, Iqbal K (2001b) Interaction of tau isoforms with Alzheimer’s disease abnormally hyperphos-phorylated tau and in vitro phosphorylation into the disease-like protein. J Biol ChemGoogle Scholar
  7. : 37967–37973Google Scholar
  8. Arrigada PA, Growdon JH, Hedley-White ET, Hyman BT (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease.Neurology 42: 631–639CrossRefGoogle Scholar
  9. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F,Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer’s disease. Brain Res 477: 90–99Google Scholar
  10. Bennecib M, Gong C-X, Grundke-Iqbal I, Iqbal K (2001) Inhibition of PP-2A upregulates CaMKII in rat forebrain and induces hyperphosphorylation of tau at Ser 262/356. FEBS Lett 490: 15–22PubMedCrossRefGoogle Scholar
  11. Cohen P (1989) The structure and regulation of protein phosphatases. Ann Rev Biochem 58: 453–508PubMedCrossRefGoogle Scholar
  12. Cohen P, Alemany S, Hemmings BA, Resink TJ, Stralfors P, Lim Tung HY (1988) Protein Phosphatase-1 and Protein Phosphatase-2A from rabbit skeletal muscle. Meth Enzymol 159: 390–408PubMedCrossRefGoogle Scholar
  13. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH (1988) Alzheimer’s disease: a double-labeling immunohistochemical study of senile plaques. Am J Pathol 132:86–101PubMedGoogle Scholar
  14. Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen S-H, Aronson M (1991) Identification of normal and pathological aging in prospectively studied non-demented elderly humans. Neurobiol Aging 13: 179–189CrossRefGoogle Scholar
  15. Finch C, Tanzi RE (1997) Genetics of aging. Science 278: 407–411PubMedCrossRefGoogle Scholar
  16. Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer’s disease. Neuron 3: 519–526PubMedCrossRefGoogle Scholar
  17. Gong C-X, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61: 921–927PubMedCrossRefGoogle Scholar
  18. Gong C-X, Shaikh S, Wang J-Z, Zaidi T, Grundke-Iqbal I, Iqbal K (1995) Phosphatase activity towards abnormally phosphorylated x: decrease in Alzheimer disease brain. J Neurochem 65: 732–738PubMedCrossRefGoogle Scholar
  19. Gong C-X, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. J Biol Chem 275: 5535–5544PubMedCrossRefGoogle Scholar
  20. Grundke-Iqbal I, Iqbal K, Quinlan M, Tung Y-C, Zaidi MS, Wisniewski HM (1986a) Microtubule-associated protein tau: a component of Alzheimer paired helical filaments. J Biol Chem 261: 6084–6089Google Scholar
  21. Grundke-Iqbal I, Iqbal K, Tung Y-C, Quinlan M, Wisniewski HM, Binder LI (1986b) Abnormal phosphorylation of the microtubule associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83: 4913–4917CrossRefGoogle Scholar
  22. Hu YY, He SS, Wang X, Duan QH, Grundke-Iqbal I, Iqbal K, Wang JZ (2002) Levels of nonphosphorylated and phosphorylated tau in CSF of Alzheimer disease patients: an ultrasensitive bienzyme-substrate-recycle ELISa. Am J Pathol 160:1269–1278PubMedCrossRefGoogle Scholar
  23. Hutton M, et al (1998) Association of missense and 5’-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393: 702–705PubMedCrossRefGoogle Scholar
  24. Iqbal K, Grundke-Iqbal I (2000) Metabolic hypothesis, mechanism and therapeutic targets of Alzheimer neurofibrillary degeneration. Neurosci News 3: 14–20Google Scholar
  25. Iqbal K, Grundke-Iqbal I, Zaidi T, Merz PA, Wen GY, Shaikh SS, Wisniewski HM, Alafuzoff I, Winblad B (1986) Defective brain microtubule assembly in Alzheimer’s disease. Lancet ii: 421–426Google Scholar
  26. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, Zaidi T (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc Natl Acad Sci USA 86: 5646–5650PubMedCrossRefGoogle Scholar
  27. Iqbal K, Zaidi T, Bancher C, Grundke-Iqbal I (1994) Alzheimer paired helical filaments: restoration of the biological activity by dephosphorylation. FEBS Lett 349: 104–108PubMedCrossRefGoogle Scholar
  28. Iqbal K, Alonso A del C, Gondal J A, Gong C-X, Haque N, Khatoon S, Sengupta A, Wang J-Z, Grundke-Iqbal I (2000) Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach. J Neural Transm 59: 213–222Google Scholar
  29. Katzman R, Terry RD, DeTeresa R, Brown R, Davies P, Fuld P, Renling X, Peck A (1988) Clinical, pathological and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol 23:138–144PubMedCrossRefGoogle Scholar
  30. Khatoon S, Grundke-Iqbal I, Iqbal K (1992) Brain levels of microtubule-associated protein tau are elevated in Alzheimer’s disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem 59: 750–753PubMedCrossRefGoogle Scholar
  31. Khatoon S, Grundke-Iqbal I, Iqbal K (1994) Levels of normal and abnormally phospho-rylated tau in different cellular and regional compartments of Alzheimer disease and control brains. FEES Lett 351: 80–84CrossRefGoogle Scholar
  32. Kopke E, Tung Y-C, Shaikh S, Alonso A del C, Iqbal K, Grundke-Iqbal I (1993) Microtubule associated protein tau: abnormal phosphorylation of non-paired helical filament pool in Alzheimer disease. J Biol Chem 268: 24374–24384PubMedGoogle Scholar
  33. Lee VM-Y, Balin BJ, Otvos Jr L, Trojanowski JQ (1991) A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science 251: 675–678PubMedCrossRefGoogle Scholar
  34. Li M, Guo H, Damuni Z (1995) Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 34: 1988–1996PubMedCrossRefGoogle Scholar
  35. Li M, Makkinje A, Damuni Z (1996a) Molecular identification of I 1 FP2A a novel potent heat-stable inhibitor protein of protein phosphatase 2A. Biochemistry 35: 6998–7002CrossRefGoogle Scholar
  36. Li M, Makkinje A, Damuni Z (1996b) The Myeloid Leukemia-associated protein SET is a potent inhibitor of Protein Phosphatase 2A. J Biol Chem 271: 11059–11062CrossRefGoogle Scholar
  37. Mah VH, Eskin TA, Kazee AM, Lapham L, Higgins GA (1992) In situ hybridization of calcium/calmodulin dependent protein kinase II and tau mRNAs; species differences and relative preservation in Alzheimer’s disease. Brain Res Mol Brain Res 12: 85–94PubMedCrossRefGoogle Scholar
  38. Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58: 188–197PubMedCrossRefGoogle Scholar
  39. Oliver CJ, Shenolikar S (1998) Physiologic importance of protein phosphatase inhibitors. Frontiers Biosci 3: 961–972Google Scholar
  40. Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L, Andreadis A, Wiederholt WC, Raskind M, Schellenberg GD (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43: 815–825PubMedCrossRefGoogle Scholar
  41. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 95: 7737–7741PubMedCrossRefGoogle Scholar
  42. Ulitzur N, Rancano C, Pfeffer SR (1997) Biochemical characterization of mapmodulin, a protein that binds microtubule-associated proteins. J Biol Chem 272: 30577–30582PubMedCrossRefGoogle Scholar
  43. von Lindern M, van Baal S, Wiegant J, Raap A, Hagemeijer A, Grosveld G (1992) can, a putative oncogene associated with Myeloid Leukemogenesis, may be activated by fusion of its 3’ half to different genes: characterization of the set gene. Mol Cell Biol 12: 3346–3355Google Scholar
  44. Wang J-Z, Gong C-X, Zaidi T, Grundke-Iqbal I, Iqbal K (1995) Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J Biol Chem 270: 4854–4860PubMedCrossRefGoogle Scholar
  45. Wang J-Z, Grundke-Iqbal I, Iqbal K (1996) Restoration of biological activity of Alzheimer abnormally phosphorylated by dephosphorylation with protein phosphatase-2A, -2B and -1. Mol Brain Res 38: 200–208PubMedCrossRefGoogle Scholar
  46. Walaas SI, Greengard P (1991) Protein phosphorylation and neuronal function.Pharmacol Rev 43: 299–349PubMedGoogle Scholar
  47. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72: 1858–1862PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2002

Authors and Affiliations

  • K. Iqbal
    • 1
  • A.C. del Alonso
    • 1
  • E. El-Akkad
    • 1
  • C.-X. Gong
    • 1
  • N. Haque
    • 1
  • S. Khatoon
    • 1
  • I. Tsujio
    • 1
  • I. Grundke-Iqbal
    • 1
  1. 1.New York State Institute for Basic Research in Developmental DisabilitiesStaten IslandNYUSA

Personalised recommendations